MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
  • Narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata in a patient with anti-Ma associated encephalitis.

    C. Espinoza-Vinces, A. Horrillo, R. Villino, A. Solis, P. Domínguez, J. Arbizu, MR. Luquin, E. Urrestarazu, I. Avilés-Olmos (Pamplona, Spain)

  • Narrative review of the efficacy of the efficacy of transcranial magnetic stimulation with patients with Parkinson disease.

    A. Elaraby, M. Shaien (Gizah, Egypt)

  • National Luxembourg Sleep Study: An enriched, at risk, prodromal Parkinson’s Disease cohort

    D. Mcintyre, L. Pavelka, C. Pauly, G. van Cutsem, O. Tsurkalenko, T. Marques, C. Gomes, S. Jonsdottir, J. Welch, K. Gunter, G. Aguayo, A. Sharify, E. Rosalès-Jubal, M. Vaillant, V. Satagopam, S. Ghosh, C. Vega Moreno, K. Roomp, A. Pincherle, M. Gantenbein, N. Diederich, M. Hu, R. Krüger, L. Vilas Boas (Luxembourg, Luxembourg)

  • Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study

    N. Del Campo, P. Péran, P. Payoux, V. Rousseau, A. Drif, H. Catalá, C. Thalamas, C. Tranchant, F. Duriff, A. Marques, JP. Azulay, C. Moreau, JC. Corvol, S. Thobois, AG. Corbille, S. Frismand, B. Patterson, A. Foubert-Samier, A. Pavy-Letraon, M. Fabbri, W. Meissner, O. Rascol (Toulouse, France)

  • Navigating Open Science in Canada with the Canadian Open Parkinson Network

    M. Cressatti, C. Normandeau, C. Degroot, I. Kathol, A. Stoessl, M. Mckeown, J. Miyasaki, R. Camicioli, D. Grimes, L. Kalia, A. Strafella, P. Macdonald, N. Dupré, E. Fon, O. Monchi (Calgary, Canada)

  • Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms

    J. Goldman, H. Peirce, D. Merkitch (Chicago, USA)

  • Needs assessment of patients with Parkinson’s disease: a qualitative study

    N. Geraminejad, A. Darvishpoor Kakhki (Tehran, Islamic Republic of Iran)

  • Network analysis of brain perfusion in [11C]UCB-J PET: Parkinson’s related motor pattern (PDRP)

    P. Honhar, S. Tinaz, S. Holmes, M. Dias, M. Naganawa, J. Gallezot, S. Henry, R. Comley, N. Nabulsi, Y. Huang, A. Hillmer, R. Carson, S. Finnema, D. Matuskey (New Haven, USA)

  • Network attack tolerance: A resilience proxy for Parkinson’s disease?

    A. Asendorf, A. Temizyürek, M. Banwinkler, V. Dzialas, THE. Parkinson-Progression-Marker-Initiative, T. van Eimeren, M. Hoenig (Cologne, Germany)

  • Network localization of limb ataxia

    J. Pullinen, O. Liesmäki, O. Likitalo, A. Bellmunt Gil, J. Aaltonen, E. Mäkinen, E. Ellis, P. Ylikotila, J. Joutsa (Turku, Finland)

  • Neural activity in pedunculopontine nucleus during sleep

    J. Maclean, J. Olaya, M. Liker, J. Nataraj, S. Javadzadeh No, SA. Seyyed Mousavi, T. Sanger (Orange, USA)

  • Neurite Orientation Dispersion and Density Imaging and Diffusion Kurtosis Imaging in Brainstem Nuclei for Subtypes of Parkinson’s Disease

    N. Joshi, I. Aisles, I. Shelley, K. Talekar, M. Alizadeh (Philadelphia, USA)

  • Neurodegeneration with Brain Iron Accumulation: A case series from a single center in India

    A. Agarwal, D. Garg, D. Radhakrishnan, R. Rajan, A. Garg, A. Srivastava (New Delhi, India)

  • Neurofilament light chain in Huntington’s Disease Like 2: a cross-sectional comparison with Huntington’s Disease.

    DG. Anderson, A. Ferreira-Correia, F. Rodrigues, L. Byrne, EJ. Wild, A. Krause (Glasgow, United Kingdom)

  • Neurofilament light chain, tau-PET and microglia-PET predict clinical progression in amyloid-negative corticobasal syndrome

    C. Palleis, N. Franzmeier, E. Weidinger, S. Katzdobler, N. Albert, O. Sabri, H. Barthel, R. Rupprecht, BS. Rauchmann, R. Perneczky, C. Haass, J. Levin, M. Brendel, GU. Hoeglinger (Munich, Germany)

  • Neurogenic Orthostatic Hypotension in Parkinson’s Disease: Is there a role for Locus Coeruleus Magnetic Resonance Imaging?

    G. Palermo, G. Bellini, A. Galgani, F. Lombardo, N. Martini, R. Morganti, D. Paoli, S. de Cori, FS. Giorgi, R. Ceravolo (Pisa, Italy)

  • Neurogenic orthostatic hypotension is not associated with generalized dysautonomia in early motor PD

    J. Li, J. Ruiz Tejeda, D. Tran, S. Nguyen, N. Phielipp (Irvine, USA)

  • Neuroimaging analysis of postural instability in Progressive Supranuclear Palsy: a Voxel‐based morphometry approach

    C. Calomino, MG. Bianco, J. Buonocore, F. Aracri, M. de Maria, A. Sarica, A. Quattrone (Catanzaro, Italy)

  • Neuroimaging and correlation with functional status in children with cerebral palsy

    M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, S. Nagi, I. Ben Youssef-Turki (Tunis, Tunisia)

  • Neuroimaging correlates of postural instability in motor subtypes of Parkinson’s disease

    A. Quattrone, C. Calomino, A. Sarica, M. Caligiuri, M. Bianco, B. Vescio, J. Buonocore, M. Vaccaro, A. Quattrone (Catanzaro, Italy)

  • Neurologic dysfunction assessment in Parkinson’s disease based on fundus photographs using deep learning

    S. Ahn, J. Shin, SJ. Song, WT. Yoon (Suwon, Republic of Korea)

  • Neurologic Music Therapy (NMT) and Non-Invasive Stimulation for Upper Extremity Performance in Patients with Corticobasal Syndrome (CBS)

    K. Kang, A. Pantelyat (Baltimore, USA)

  • Neurologic music therapy for fine motor rehabilitation in Huntington’s disease: a pilot study

    E. Forbes, L. Lattanzio, L. Quiller, L. Seeberger, I. Buard (Aurora, USA)

  • Neurological symptom severity in Wilson disease is associated with increased white matter mean diffusivity

    A. Hausmann, S. Kannenberg, C. Hartmann, J. Caspers, C. Rubbert, A. Schnitzler (Duesseldorf, Germany)

  • Neuromelanin related 7T MRI of the locus coeruleus differs between Parkinson’s disease and controls

    A. Wolters, M. Heijmans, N. Priovoulos, H. Jacobs, A. Postma, Y. Temel, M. Kuijf, S. Michielse (Maastricht, Netherlands)

  • Neuromyotonia in surgical scars: two case reports and review of literature.

    I. Amorín, J. Hackembruch, M. Nocera (Montevideo, Uruguay)

  • Neuropalliative communication curriculum: A review of the literature and needs assessment

    K. Block, A. Hiller, N. Leavell, S. Sorge (Portland, USA)

  • Neuropathic mechanism of paroxysmal kinesigenic dyskinesia based on EEG

    XJ. Huang, HC. Luo, TF. Yuan, L. Cao (Shanghai, China)

  • Neurophysiological analysis of the posterior subthalamic area in a patient with Holmes’ tremor

    M. Wilken, I. Cruz Varela, F. Villamil, S. Castillo Torres, M. Merello (Buenos Aires, Argentina)

  • Neurophysiological architecture of visual categorization in early Parkinson’s disease with minor hallucinations

    L. Perez-Carasol, S. Martinez-Horta, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

  • Neurophysiological markers of motor reserve in Parkinson’s disease

    M. Passaretti, S. Rinaldo, E. Orunesu, D. Rossi Sebastiano, G. de Vigili, G. Barbiera, A. Braccia, G. Paparella, M. de Riggi, P. Lanteri, A. Berardelli, A P. Strafella, M. Bologna, R. Eleopra, R. Cilia (Rome, Italy)

  • Neuroprotective effects of oral consumption of Bifidobacterium lactis and Lactobacillus acidophilus probiotics on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropytide-induced Parkinson’s Disease mouse model

    C. Mo, Y. Qian, Y. Zhang, X. He, Y. Lai, S. Xu, P. Ai, X. Yang, Q. Xiao (Shanghai, China)

  • Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

    A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

  • Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

    C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

  • Neuropsychological and quality of life outcome comparison after awake and asleep pallidal deep brain stimulation (DBS) surgery for Parkinson’s disease

    A. Tröster, A. Novak, S. Russell, K. Hanson (Phoenix, USA)

  • Neuropsychological Outcomes After Bilateral Focused Ultrasound Thalamotomy within Essential Tremor

    M. Obolsky, N. Amitrano, N. Patel, S. Sani, M. Afshari, M. Wodziak, B. Bernard, S. Anderson, D. Gonzalez (Chicago, USA)

  • Neurotological evaluation on cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (canvas)

    B. Leao, M. Severiano, G. Santos, H. Teive, M. José, B. Cavalcante-Leao, C. Araújo (Curitiba, Brazil)

  • New DBS targets for dystonia in thalamus and brainstem

    T. Sanger, J. Maclean, J. Olaya, M. Liker (Orange, USA)

  • New machine learning approaches in tic detection: Seeking to learn more about the characteristic of tics

    L. Becker, R. Schappert, N. Brügge, G. Sallandt, F. Li, J. Friedrich, T. Bäumer, C. Frings, C. Beste, R. Stenger, V. Roessner, H. Handels, S. Fudickar, A. Münchau (Lübeck, Germany)

  • New wearable technology for quantification of freezing of gait in school going adolescent with pediatric movement disorders

    V. Sharma, M. Gautam (Agra, India)

  • Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy

    MC. Kuo, SP. Lin, RM. Wu (Taipei, Taiwan)

  • NLX-112 has favorable safety and tolerability and displays efficacy against levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD)

    P. Svenningsson, P. Odin, F. Berquist, K. Wirdefeldt, D. Nyholm, M. Andréasson, I. Markaki, A. Johansson, M. Jergil, C. Jankosky, M. Varney, F. Herbrecht, S. Johnson, A. Newman-Tancredi (Solna, Sweden)

  • No laughing white matter: reduced integrity of the lateral nucleus basalis of Meynert pathway in Parkinson’s disease-related cognitive impairment

    R. Crockett, K. Wilkins, S. Aditham, H. Bronte-Stewart (Stanford, USA)

  • Nocturnal behavior of people with Parkinson’s disease

    C. Duval, A. Karelis, J. Daneault (Montreal, Canada)

  • Non classified SCA-like presentation of GEMIN5 + GYG-1 mutation. Case report

    A. Escalante Mercado, G. Calderon Paiva, J. Medina Suárez, P. Gonzales Romero, W. Trillo Alvarez, J. Calderon Paiva, P. Bermejo Rosado, A. Aquino Toledo, L. Chavez Torreblanca (Arequipa, Peru)

  • Non-intrusive Video-Based Solution for Continuous Quantitative Monitoring of Parkinson’s Patients’ Motor Functions

    A-S. Bridoux, G. Altares, G. Garraux, M. Koivu, L. Mäkitie, E. Fiorenzato, L. Weis, A. Antonini, A. Nieuwboer (Mons, Belgium)

  • Non-invasive Vagus Nerve Stimulation Alters Molecular Markers in Parkinson’s Disease Patients with Freezing of Gait

    R. Banerjee, B. Mondal, S. Choudhury, A. Roy, K. Chatterjee, P. Basu, S. Baker, M. Baker, H. Kumar (Kolkata, India)

  • Non-motor symptoms of Parkinson’s disease: an analysis of gender and age-related differences in a large online cohort

    D. Teixeira-Dos-Santos, G. Pereira, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

  • Non-motor Symptoms Progression in Parkinson´s Disease. A 4-year Follow-up Study.

    D. Santos, T. de Deus, C. Cores, M. Feal Painceiras, I. García-Díaz, M. íñiguez, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

  • Non-tremor motor dysfunction in Parkinson’s disease is associated with decreased [18F]FMPEP-d2 binding

    R. Ajalin, H. Al-Abdulrasul, J. Tuisku, J. Hirvonen, S. Lahdenpohja, J. Rinne, A. Brück (Espoo, Finland)

  • Nonketotic hyperglycemia-induced hemichorea/hemiballism in El Salvador: A case Series

    R. Lopez-Castellanos, R. Lopez-Contreras (Atlanta, USA)

  • Normative data for the Vietnamese smell identification test

    T. Dang, K. Vo, U. Ha, Q. Ly, T. Thai, T. Nguyen, T. Tran (HO CHI MINH, Viet Nam)

  • Normative values for the Instrumented Timed Up and Go test in Parkinsonian populations

    L. Palmerini, I. D'Ascanio, A. Giannoni, G. Calandra-Buonaura, G. Giannini, L. Chiari, P. Cortelli, G. Lopane (Bologna, Italy)

  • Novel application of the Timed Up and Go Scale as a reliable tool to measure functional improvement and fall prevention after inpatient Parkinson’s Disease specific rehabilitation for advanced stages of PD

    M. Mccrossin, L. Rubin, C. Claro, A. Persaud, E. Finlay, A. Sturman, D. Barreto, A. John, M. Tursi, A. Di Rocco (Glen Cove, USA)

  • Novel CACNA1A splice site variant associated with cerebellar ataxia and mild cognitive impairment; case report of Czech family.

    A. Afifi, M. Nevrly, Z. Musova, P. Hedvicakova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

  • Novel digital marker detects minor hallucinations online at home of patients with Parkinson’s disease

    L. Albert, F. Bernasconi, J. Potheegadoo, B. Herbelin, O. Blanke (Geneva, Switzerland)

  • Novel modifiers of heterozygous pathogenic Parkin variant penetrance in Parkinson’s disease

    A. Hach, Z. Landoulsi, B. Meier, P. Seibler, C. Klein, P. May, A. Rakovic (Luebeck, Germany)

  • Novel RAB39B stop mutation in patient with typical Early-Onset Parkinson’s disease

    J. Jacobson, C. Piat, O. Ross, R. Savica (Rochester, USA)

  • Novel utilization of deep brain stimulation in the pedunculopontine nucleus for treatment of childhood-onset dystonia

    J. Davies, J. Kurtz, J. Maclean, T. Sanger, M. Liker, J. Olaya (Orange, USA)

  • Novelty Seeking: A Narrative Review

    K. Paulk, L. Neilson (Portland, USA)

  • NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.

    H. Berven, S. Kverneng, E. Sheard, M. Søgnen, S. Geijerstam, K. Haugarvoll, GO. Skeie, C. Dölle, C. Tzoulis (Bergen, Norway)

  • Nucleus basalis of Meynert and total gray matter atrophy are related to cognitive and gait decline in Parkinson’s disease

    A. Yeung, F. Ba, M. Gee, R. Camicioli (Edmonton, Canada)

  • Nutritional traits in the prodromal phase on Parkinson’s disease in community-dwelling older adults in Japan

    T. Yamaguchi, R. Nozaki, K. Taguchi, Y. Suzuki, K. Takahashi, K. Takahashi, K. Iwaoka, Y. Sato, T. Terauchi, H. Akasaka, N. Ishizuka, T. Maeda (Iwate, Japan)

Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley